BMY NYSE
Bristol-Myers Squibb Company
1W: +4.9%
1M: +1.2%
3M: -1.9%
YTD: +11.3%
1Y: +27.8%
3Y: -0.2%
5Y: +9.7%
$59.46
-0.09 (-0.15%)
Weekly Expected Move ±3.9%
$53
$55
$57
$59
$61
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.15
Neutral
6 bullish
2 neutral
4 bearish
Articles (7d)
12
Daily Sentiment (7 Days)
Articles (100)
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell?
The Most Undervalued Healthcare Stock in the S&P 500 Right Now
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
Bristol-Myers taps Anthropic's Claude for 30,000 workers
Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B
Teva Stock Up More Than 100% in a Year: Time to Buy, Hold or Sell?
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law
Regeneron's Late-Stage Melanoma Study Misses Primary Goal
3 High-Yielding Dividend Stocks Trading at Dirt Cheap Valuations
Regeneron hit with late-stage trial setback for Libtayo combo against Merck’s Keytruda
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts
Trump 'Most Favored Nation' drug policy risks China R&D takeover
10 Years Later: 5 Winners in a Thinking World
Will Keytruda Continue to Aid MRK's Growth in 2026 After a Strong Q1?
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down
4 stocks to watch on Tuesday: BMY, NVO, GOOG, AVGO
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.
Trump says unaware of a plan to fire FDA commissioner
Trump to fire FDA commissioner Marty Makary: WSJ
Prothena Posts Q1 Earnings as Revenues Surge on Milestone Payment
RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo Launch
Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier
Robert F. Kennedy Jr. Wants To Take 'Clear And Decisive Action' On Psychiatric Drugs Amid 'Deprescribing' Push: Big Pharma Should Pay Attention
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why Bristol Myers Squibb Stock Rocked the Market Today
Bristol-Myers signals 30% R&D cycle-time reduction while tracking toward upper end of 2026 guidance ranges
Why Is Bristol-Myers Squibb Stock Trading Higher On Thursday?
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings
Bristol Myers (BMY) Q1 2026 Earnings Transcript
Pharma stocks rebound on cheap valuations, patent cliff fears ease, UBS says—CNBC interview
Jobless Claims Come in Extremely Low
Econ Growth, Historically Low Jobless Claims & More Earnings
BMY's Q1 Earnings Top Estimates, Breyanzi, Camzyos Drive Sales
Bristol Myers (BMY) Reports Q1 Earnings: What Key Metrics Have to Say
Bristol Myers Squibb (BMY) Tops Q1 Earnings and Revenue Estimates
Bristol-Myers Squibb in charts: Q1 revenue from Eliquis, Yervoy, and Orencia rises Y/Y; Sprycel, Opdivo, and Pomalyst/Imnovid falls
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Bristol-Myers posts Q1 beat thanks to growth portfolio
Breakfast News: Alphabet CEO Hails AI Capex Payoff
Earnings Scheduled For April 30, 2026
Merck Q1 earnings beat lifts shares; 2026 guidance narrowed
Bristol-Myers Squibb Q1 Preview: Growth portfolio's performance in focus
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition
Incyte taps Zimmer Biomet's Suketu Upadhyay as CFO
Comerica Bank Decreases Stake in Bristol Myers Squibb Company $BMY
D.A. Davidson & CO. Purchases 28,410 Shares of Bristol Myers Squibb Company $BMY
3 Healthcare Stocks That Pay You While You Wait for the Growth
IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts
Is IBRX Priced for Perfection at Nearly 28x Forward Sales?
Will These 5 Drug Bigwigs Surpass Q1 Earnings Forecasts?
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
Exploring Analyst Estimates for Bristol Myers (BMY) Q1 Earnings, Beyond Revenue and EPS
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Drug developer Seaport Therapeutics seeks up to $212M in US IPO
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
Ashton Thomas Private Wealth LLC Trims Stock Holdings in Bristol Myers Squibb Company $BMY
Aprio Wealth Management LLC Buys 44,125 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb: Low Volatility Meets High Dividend Yield
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Advisors Capital Management LLC Raises Stake in Bristol Myers Squibb Company $BMY
AEGON ASSET MANAGEMENT UK Plc Grows Stock Position in Bristol Myers Squibb Company $BMY
Abacus FCF Advisors LLC Has $20.77 Million Stock Position in Bristol Myers Squibb Company $BMY
Earnings Scoreboard: 82% of S&P 500 early reporters top EPS estimates ahead of big tech wave
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Catalyst Watch: Earnings blitz, FOMC, Pershing Square IPO, and NYC gets a full casino
Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?
Bristol, Pfizer's Eliquis becoming available on Mark Cuban Cost Plus Drug
Bristol Myers Squibb Company $BMY Holdings Raised by Caprock Group LLC
Arizona State Retirement System Sells 22,221 Shares of Bristol Myers Squibb Company $BMY
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
61,789 Shares in Bristol Myers Squibb Company $BMY Bought by CPC Advisors LLC
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
Brighton Jones LLC Acquires 76,067 Shares of Bristol Myers Squibb Company $BMY
Fortis Capital Advisors LLC Makes New $518,000 Investment in Bristol Myers Squibb Company $BMY
Can BMY's Growth Portfolio Counter Legacy Drugs Decline in Q1?
Why Bristol Myers Squibb (BMY) is a Top Momentum Stock for the Long-Term
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
Earned Wealth Advisors LLC Has $1.14 Million Position in Bristol Myers Squibb Company $BMY
Belpointe Asset Management LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY
Assetmark Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY
Farther Finance Advisors LLC Has $4.22 Million Holdings in Bristol Myers Squibb Company $BMY
AE Wealth Management LLC Has $21.63 Million Stock Position in Bristol Myers Squibb Company $BMY
Can Myqorzo Drive Growth for Cytokinetics Amid Competition?
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
The 10 Healthcare stocks with the lowest forward P/E ratios
2 Healthcare Stocks to Buy and 1 to Approach With Caution
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
Dividend stocks to watch: 10 picks as U.S.-Iran tensions shake markets